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Abstract
Background: Neuropathy is one of the complications caused by diabetes mellitus which is directly
related to the gastrointestinal manifestations of the disease. Antioxidant substances, such as vitamin
E, may play an important role in the reduction of the neurological damage caused by diabetes
mellitus. The aim of the present study was to determine whether vitamin E (α-tocopherol) at
different concentrations induces any effects on the morphology of the intestinal wall and intrinsic
innervation in the proximal colon of diabetic rats.
Methods: Thirty rats (90-day-old) were assigned to the following groups: N (normoglycemic),
NE1 (normoglycemic supplemented with vitamin E 0.1%), NE2 (normoglycemic supplemented with
vitamin E 2%), D (diabetic), DE1 (diabetic supplemented with vitamin E 0.1%), and DE2 (diabetic
supplemented with vitamin E 2%). Animals received vitamin E supplementation for 120 days and
were sacrificed when they were 210 days old. The proximal colon of each animal was subjected to
histology to study the intestinal wall and goblet cells and processed for whole-mount preparations
to morphoquantitatively determine the total myenteric population.
Results: Supplementation with vitamin E significantly reduced glycemia and glycated hemoglobin
values and preserved the number of myenteric neurons in group DE2, without affecting intestinal
area or thickness of the intestinal wall or muscular tunic.
Conclusion: Vitamin E (2%) influenced the glycemic parameters and had a neuroprotective effect
on the total myenteric population, but the morphometric characteristics of the intestinal wall were
unaffected.
Background
Diabetes mellitus causes imbalances and pathological
changes in several tissues. All types of diabetes mellitus
are characterized by hyperglycemia and the development
of specific microvascular pathologies, including in retina
(retinopathy), renal glomeruli (nephropathy), and
Published: 23 November 2009
BMC Gastroenterology 2009, 9:88 doi:10.1186/1471-230X-9-88
Received: 1 May 2009
Accepted: 23 November 2009
This article is available from: http://www.biomedcentral.com/1471-230X/9/88
© 2009 Roldi et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 8
(page number not for citation purposes)
BMC Gastroenterology 2009, 9:88 http://www.biomedcentral.com/1471-230X/9/88peripheral nerves (neuropathy), the last of which is most
common in diabetic patients [1].
The manifestations of diabetic neuropathy lead to many
symptoms in the gastrointestinal tract, including diabetic
gastroparesy, diabetic enteropathy, esophageal motor dys-
function, colonic hypomobility, and rectum-anal dys-
function [2]. Morphological consequences of diabetic
neuropathy, such as increased total area of the intestinal
wall in the small intestine, hypertrophy [3] and hyperpla-
sia of the intestinal mucosa [4], and an increased number
of goblet cells [5], are also observed.
Vinik [6] found that diabetes-induced neuropathy in the
gastrointestinal tract is related to alterations in myenteric
neurons in the enteric nervous system that are present in
the tubular wall of the digestive tract [7]. Recent studies
have shown severe alterations of the enteric nervous sys-
tem in rat models of experimental diabetes, such as a
reduction in enteric neurons in the stomach [8], duode-
num [9], ileum [10,11], colon [12], cecum [13], and prox-
imal colon [14], and alterations in the area of neuronal
cellular bodies in the ileum [10,11], colon [12], and
cecum [13]. Hyperglycemia has been shown to be respon-
sible for the development and progression of neuropathy,
promoting loss of function and decreasing neuronal sur-
vival [15] due to alterations in blood flow, increases in
vascular permeability, and decreases in neuronal trophic
factors [16]. Accumulation of final glycation products
(AGEs), polyol pathway hyperactivity, and an increase in
oxidative stress are among the described mechanisms
explaining how hyperglycemia damages the nervous sys-
tem.
Diabetes-induced oxidative stress generates reactive oxy-
gen species and an imbalance among antioxidants. Bhor
et al. [17] reported altered activity in primary antioxidant
enzymes (e.g., catalase, superoxide dismutase, and glu-
tathione peroxidase) and an increase in lipid peroxidation
and carbonyl protein content, thus ensuring the occur-
rence of oxidative stress in diabetic rats.
Several antioxidant enzymatic and non-enzymatic sys-
tems in the cell inactivate free radicals to reduce the dam-
age caused by them. These antioxidants include
glutathione, enzymatic systems, and vitamins A, C, and E
[18]. The effect of vitamin E on free radicals is mainly
important for preventing or delaying many degenerative
diseases, such as cancer, cardiovascular inflammatory dis-
eases, cellular alterations attributable to the aging process,
and neurological diseases [19]. Vitamin E has eight differ-
ent natural forms: α-, β-, δ-, and γ-tocopherols and α-, β-,
δ-, and γ-tocotrienols. α-Tocopherol constitutes the most
biologically active form [20].
In diabetic patients, Reunanen et al. [21] verified that vita-
min E promoted a reduction in the indicators of oxidative
stress and protein glycation. Prior studies in diabetic rats
that received vitamin E treatment found a reduction in
lipid peroxidation, an increase in superoxide dismutase
activity [22], an increase in nervous system conductance
velocity [23,24], and protection against nervous system
dysfunction [25,26].
The goal of the present study was to determine whether
vitamin E (α-tocopherol) at two different concentrations
has any influence on intestinal wall morphology and
myenteric neurons in the proximal colon of diabetic rats.
Methods
Animal procedure
The present study used 30 albino male adult Wistar rats
(Rattus norvegicus) from the Central Biotery of the State
University of Maringa (UEM). All procedures described in
this study were approved by the Ethics Committee on Ani-
mal Experimentation of UEM. When rats were 90 days
old, they were kept in polypropylene boxes for 120 days
in the biotery under controlled temperature (24 ± 2°C)
and illumination (12 h/12 h light/dark cycle) with ad libi-
tum access to water and food. Animals from the normogly-
cemic (N) and diabetic (D) groups received padronized
Nuvital® chow pellets (Nuvilab, Colombo, PR, Brazil).
The groups allocated to groups NE1 and NE2 (normogly-
cemic supplemented with vitamin E 0.1% and 2%, respec-
tively) and groups DE1 and DE2 (diabetics supplemented
with vitamin E 0.1% and 2%, respectively) received vita-
min E (α-tocopherol; Zhejiang NHU, China) supplemen-
tation added to the padronized chow at concentrations of
0.1% [23] and 2%.
Animals were allocated to one of six groups (n = 5/group):
N (normoglycemic rats receiving padronized chow), NE1
(normoglycemic rats receiving padronized chow supple-
mented with vitamin E 0.1%), NE2 (normoglycemic rats
receiving padronized chow supplemented with vitamin E
2%), D (diabetic rats receiving padronized chow), DE1
(diabetic rats receiving padronized chow supplemented
with vitamin E 0.1%), and DE2 (diabetic rats receiving
padronized chow supplemented with vitamin E 2%).
To induce diabetes, after prior fasting for 14 h, animals
from groups D, DE1, and DE2 were injected (into the
penis vein) with streptozotocin (Sigma, St. Louis, MO,
USA) at a concentration of 35 mg/kg body weight [27] dis-
solved in 10 mM citrate buffer, pH 4.5.
Glucose levels after diabetes induction were determined
by the glucose oxidase method [28] to confirm induction
of the disease. Only animals with >250 mg/dl glycemia
were retained in groups D, DE1, and DE2.Page 2 of 8
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After 120 days of experimentation, animals were weighed,
intraperitoneally anesthetized with thiopental (40 mg/kg
body weigh; Abbott Laboratories, Chicago, IL, USA), and
sacrificed. Blood was collected by heart puncture and
stored in heparinized flasks, and the plasma portion was
used to evaluate the levels of glycemia and glycated hemo-
globin [29].
After laparotomy, the large intestine was collected, and its
length and circumference were measured to obtain the
area. Additionally, segments of the proximal colon were
collected. Some samples were designated to the histologi-
cal study of the intestinal wall and the Periodic Acid-Schiff
histochemical technique to identify goblet cells. The other
samples were subjected to whole-mount preparations
stained using the Giemsa method for the morphoquanti-
tative study of total myenteric population.
Study of the intestinal wall
Samples of the proximal colon were opened along the
mesocolic region and distended on an isoprene plate. The
mucosa was then exposed and washed with saline solu-
tion to remove feces. Segments were then fixed in Bouin
solution for 12 h and stored in 70% alcohol. Segments
underwent two mean inclusions: (1) in paraffin to obtain
semi-seriated sections of 7 μm thickness each and sub-
jected to hematoxilin and eosin (HE) staining and (2) in
historesin (LKB, Technovit 7100) to obtain semi-seriated
sections of 7 μm thickness each to histochemically iden-
tify glycoproteins present in intestinal goblet cells using
the PAS method.
Images of the obtained sections were captured using a
high-resolution camera (Q Color 3, Olympus America)
coupled to a light microscope (Olympus BX40). Morpho-
metric and quantitative analyses were performed with the
aid of Image Pro Plus® 4.5 image analysis software (Media
Cybernetics, Silver Spring, MD, USA).
Images of the sections stained with HE were used to meas-
ure the thickness of the mucous and muscular tunic and
total intestinal wall at 10 points chosen randomly, with
five sections per animal, for a total of 250 measures per
group. Images of sections obtained using the PAS histo-
chemical method were used to quantify goblet cells
present in 50 images per animal (40× objective). The area
of each image was 0.01 mm2. Results are expressed as the
number of goblet cells per mm2.
Quantitative and morphometric study of myenteric 
neurons
Proximal colon samples from five animals per group were
collected to evaluate the total population of myenteric
neurons using the Giemsa method [30]. After collection,
segments were washed in saline solution, filled with
Giemsa fixative, and embedded in this solution for 24 h.
Segments were opened at the mesocolic region and micro-
dissected under a stereomicroscope with transillumina-
tion by removing the mucosa and submucosa layers and
preserving the muscular tunic and serosa. Sequential
whole-mount preparations were stained by the Giemsa
method in Sorensen's phosphate buffer 0.1 N (pH 6.9) for
24 h at room temperature. Sections were then dehydrated
in a series of increasing ethanol concentrations, diapha-
nized in xylol, and mounted and coverslipped on slides
using Permount®.
Quantitative analysis
Using an Olympus optical microscope with a 40× objec-
tive, we quantified the number of myenteric neurons
present in 40 microscopic fields in the intermediate
regions (60°-120°, 240°-300°) and 40 microscopic fields
in the anti-mesocolic regions (120°-240°) of the intesti-
nal circumference, with 0° as the mesocolon insertion
(Figure 1) [31]. Each field corresponded to 0.18 mm2, for
a total of 14.4 mm2/animal.
Morphometric analyses
To evaluate the area of the cellular bodies (cellular profile)
of myenteric neurons, 500 neurons per group were meas-
ured. Images were obtained using a high-resolution cam-
era coupled to an optical microscope. Morphometric
analyses were performed using Image Pro Plus® 4.5 image
analysis software (Media Cybernetics, Silver Spring, MD,
USA).
Statistical analysis
Statistical analysis was performed using GraphPad Prism®
3.0 (GraphPad Software, San Diego, CA, USA). Analysis of
(a) Transverse section of the intestine: 0° represents the mesocolon insertion, 0°-60° a d 300°-360° the mesocolic regi ns, 60°-120° a d 240°-300° the intermediat  regi n, and 120°-240° the antimesocolic region of the int tinal ir-cumferencFi u e 1
(a) Transverse section of the intestine: 0° represents 
the mesocolon insertion, 0°-60° and 300°-360° the 
mesocolic regions, 60°-120° and 240°-300° the inter-
mediate region, and 120°-240° the antimesocolic 
region of the intestinal circumference. (b) Intestinal 
segment opened along the mesocolic edge (M, mesocolic 
region; I, intermediate region; AM antimesocolic region) [31].Page 3 of 8
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compare mean values. Levels of p < 0.05 were considered
statistically significant. Results are expressed as mean ±
standard error.
Results
Streptozotocin promoted the development of a diabetic
syndrome in animals from groups D, DE1, and DE2, ver-
ified as an increase in glycemia and glycated hemoglobin
(Table 1). During the experimental period, typical clinic
manifestations of the disease were observed, such as poly-
phagia, polydipsia, polyuria, and a reduction in body
weight compared with normoglycemic animals.
Supplementation with vitamin E (2%) significantly
reduced glycemia levels and glycated hemoglobin com-
pared with animals from groups D and DE1 (p < 0.001).
This vitamin E concentration also reduced glycated hemo-
globin in the normoglycemic supplementation group
(NE2). Supplementation with vitamin E 0.1% did not
alter glycemia levels or glycated hemoglobin in group
DE1 compared with group D (p < 0.05). Animals from
groups DE1 and DE2 exhibited less weight loss compared
with untreated diabetic animals (p > 0.05) (Table 1).
The area of the large intestine was significantly greater in
diabetic animals compared with animals from group N (p
< 0.001) and not altered by either concentration of vita-
min E supplementation (Table 1).
Morphometric analysis of the intestinal wall
The total intestinal wall and muscular tunic in diabetic
animals were significantly reduced compared with non-
diabetic animals (p < 0.05) (Figure 2) but maintained
their typical histological organization. Vitamin E supple-
mentation did not promote any reversal of this parameter.
The thickness of the mucous tunic was maintained among
groups.
Quantitative analysis of intestinal goblet cells
The number of goblet cells present in 0.5 mm2 per animal
was not statistically different among groups. The average
number of goblet cells for each group was: N (8896 ±
400.1), NE1 (7613 ± 344.5), NE2 (8246 ± 543.7), D
(8532 ± 255.4), DE1 (7427 ± 392.5), and DE2 (7315 ±
376.3).
Quantitative analysis of total myenteric neuron 
population
Considering the whole-mount preparations stained by the
Giemsa method, observing the maintenance of ganglia
arrangement was possible, which ranged according to
number and size, with sparse isolated neurons independ-
ent of group.
Neuronal counting was performed in the antimesocolic
and intermediate regions of the proximal colon. These
values were not significantly different; therefore, these
data were collapsed. The experimental diabetes condition
promoted a reduction in the number of myenteric neu-
rons in groups D (2805 ± 176.9) and DE1 (2797 ± 70.0)
compared with groups N (3929 ± 149.7), NE1 (3820 ±
179.0), and NE2 (4224 ± 262.8) (p < 0.05). A positive
effect of vitamin E (2%) was confirmed. Neuronal popu-
lation in group DE2 (3923 ± 78.95) was significantly dif-
ferent compared with groups D and DE1 (p < 0.05)
(Figure 3).
Morphometric analysis of total myenteric neuron 
population
The mean areas for myenteric neurons (μm2) in the stud-
ied groups were the following: N (283.9 ± 16.3), NE1
(267.7 ± 13.5), NE2 (265.6 ± 30.4), D (304.4 ± 13.7),
DE1 (306.5 ± 13.3), and DE2 (267.3 ± 13.4). Compari-
sons between groups N and D did not reveal any signifi-
cant differences (p > 0.05) (Figure 4). Despite the lack of
differences, animals from group DE2 exhibited a reduc-
tion in cellular body area compared with groups D and
DE1 (p < 0.05). A range from 201 to 300 μm2 was the pre-
dominant cellular profile for all groups.
Discussion
Streptozotocin effectively induced experimental diabetes
in the present study, reflected by an increase in glycemia
Table 1: Glycemia, glycated hemoglobin, final body weight, and large intestine area.
Group Glycemia (mg/dl) Glycated hemoglobin (%) Final weight (g) Intestinal area (cm2)
N 178.2 ± 17.3a 3.16 ± 0.13a 450.3 ± 15.6a 18.75 ± 1.6a
NE1 147.2 ± 8.3a 3.64 ± 0.26a 419.2 ± 12.6a 20.35 ± 59a
NE2 128 ± 6.4a 2.54 ± 0.05b 406.7 ± 9.8a 20.42 ± 3.7a
D 489.6 ± 7.2b 6.15 ± 0.45c 268.2 ± 14.5b 36.82 ± 3.8b
DE1 525.2 ± 23.2b 6.50 ± 0.10c 291.3 ± 21.9b 32.44 ± 5.2b
DE2 319.7 ± 3.6c 4.78 ± 0.13d 290 ± 21.7b 29.46 ± 3.7b
N, normoglycemic; NE1, normoglycemic supplemented with vitamin E (0.1%); NE2, normoglycemic supplemented with vitamin E (2%); D, diabetic; 
DE1, diabetic supplemented with vitamin E (0.1%); DE2, diabetic supplemented with vitamin E (2%). Mean ± standard error (n = 5). Means followed 
by different letters in the same column are statistically different (Tukey's test, p < 0.05).Page 4 of 8
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and DE2. The typical characteristics of a diabetic condi-
tion were also observed when these animals were com-
pared with groups N, NE1, and NE2, such as polyphagia,
polydipsia, and polyuria. These typical clinical manifesta-
tions were not experimentally assessed in the present
experiment but were generally observed during the ani-
mal's daily behavior. These manifestations in diabetic
rodents have been frequently found in our previous exper-
iments which induced experimental diabetes with the
same drug [14,32].
Diabetic animals that received vitamin E (2%) supple-
mentation exhibited a significant reduction in glycemia
and glycated hemoglobin compared groups D and DE1,
indicating a positive effect of this antioxidant on blood
glycemia. Shirpoor et al. [22], in a study performed with
diabetic rats that received vitamin E (300 mg/kg body
weight), observed a significant reduction in blood glucose
and glycated hemoglobin in treated diabetic animals
compared with untreated diabetic animals. Another study
also performed with diabetic rats supplemented with vita-
min E (650 mg/kg body weigh) demonstrated that glu-
cose blood levels were reduced in supplemented diabetic
animals compared with untreated diabetic animals [33].
Although these authors observed a reduction in glycemia
with lower concentrations of vitamin E than those used in
the present study, daily intake of vitamin E (2%) in chow
averaged 900 mg. The route of administration was also
different (vitamin E in water [22] and vitamin E through
gavage [34]), suggesting that the route of administration
is important when the effects of this antioxidant are eval-
uated and that supplementation in chow demands higher
vitamin E concentrations [23].
The mechanism by which the antioxidant reduced blood
glucose levels has not yet been established. Antioxidants
increase glucose metabolism in peripheral tissues, leading
to a decrease in plasma glucose levels [33]. This fact could
explain the reduction in glycated hemoglobin promoted
by vitamin E in animals from group NE2. Further studies
are needed to determine the relationship between vitamin
Morphometry of the intestinal wall, mucous tunic, muscular tunic, and total wall of rats from groups N (normoglycemic), NE1 (n rm glycemic supplemented with vitamin E 0.1%), 2 2%), D (diabetic), DE1 (diabetic suppl m nted with vita in E 0.1%and DE2 (diabetic suppl m nt d wi h vitami  E 2%)Figure 2
Morphometry of the intestinal wall, mucous tunic, 
muscular tunic, and total wall of rats from groups N 
(normoglycemic), NE1 (normoglycemic supple-
mented with vitamin E 0.1%), NE2 (normoglycemic 
supplemented with vitamin E 2%), D (diabetic), DE1 
(diabetic supplemented with vitamin E 0.1%), and 
DE2 (diabetic supplemented with vitamin E 2%). Mean 
± standard error (n = 5). *p < 0.05, compared with the other 
groups.
Number of myenteric neurons quantified in 14.4 mm2 of the proximal colon of animals from groups N (normoglycemic), E1 (normoglycemic supplemented w th vitamin E 0.1%), 2 2%), D (diabetic), DE1 (di betic uppl m nted with vitamin E 0.1%),and DE2 (diabetic suppl m nt d wi h vitamin E 2%)Figur  3
Number of myenteric neurons quantified in 14.4 
mm2 of the proximal colon of animals from groups N 
(normoglycemic), NE1 (normoglycemic supple-
mented with vitamin E 0.1%), NE2 (normoglycemic 
supplemented with vitamin E 2%), D (diabetic), DE1 
(diabetic supplemented with vitamin E 0.1%), and 
DE2 (diabetic supplemented with vitamin E 2%). Mean 
± standard error (n = 5). *p < 0.05, compared with the other 
groups.
Average areas of myenteric neurons in the proximal colon from groups N (normoglycemic), NE1 (norm glycemic sup-ple ented with vita in E 0.1%), NE2 (normoglycemi  sup-2%), D (diabe ic), DE1 (diabetic suppl m nted with vitamin E 0.1%), d DE2 (diab tFigure 4
Average areas of myenteric neurons in the proximal 
colon from groups N (normoglycemic), NE1 (normo-
glycemic supplemented with vitamin E 0.1%), NE2 
(normoglycemic supplemented with vitamin E 2%), D 
(diabetic), DE1 (diabetic supplemented with vitamin 
E 0.1%), and DE2 (diabetic supplemented with vita-
min E 2%). Mean ± standard error (n = 5). *p < 0.05, com-
pared with groups D and DE1.Page 5 of 8
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which this antioxidant reduces blood glucose levels in
experimental diabetes.
The area of the large intestine in diabetic animals was sig-
nificantly larger. A dimensional increase in organs in dia-
betic animals is often reported in the literature, for both
the small intestine [3,17,33,35] and large intestine
[13,36]. Larger cecum dimensions were observed by
Zanoni et al. [13], who attributed this change to a decrease
in muscular fiber tone, thus leading to greater dilatation.
In contrast, Miranda Neto et al. [36] attributed the larger
dimension found in the distal colon of diabetic rats as an
effect of the nitrergic population (inhibitory neurons),
thus leading to a decrease in muscular tone. In the present
study, the increase in the large intestine may be attributa-
ble to several related factors, including a reduction in
intrinsic innervation in this organ, reflected by decreased
myenteric neuronal population and decreased thickness
of the muscular tunic associated with intestinal motility.
Vitamin E supplementation did not induce any effects on
the dimensions of the large intestine in the studied
groups. Shirpoor et al. [37] observed that in the small
intestine of diabetic rats receiving vitamin E (300 mg/kg
body weight) intestinal length was not altered.
The thickness of the total intestinal wall and muscular
tunic was reduced in diabetic animals. Data from the lit-
erature reveal that the small intestine of rats responds to
experimental diabetes by increasing the total wall thick-
ness and thickness of the muscular tunic [3]. These results
do not necessarily contradict with the present study
because the previous study maintained an acute diabetes
condition and our present model maintained a chronic
condition. The decrease in total intestinal wall thickness is
a reflex to a reduction in the muscular tunic, which is a
consequence of innervation promoted by a loss of mye-
nteric neurons.
The thickness of the mucous tunic did not exhibit any sig-
nificant alterations in any of the studied groups. This
result is corroborated by a maintenance of crypts in the
proximal colon of rats with chronic diabetes [32], possi-
bly attributable to physiological adaptations in which an
increase in proliferation of intestinal crypts is not
observed. Other studies reported hypertrophy [3] and
hyperplasia [7] in the mucosa of the small intestine in rats
subjected to an acute experimental diabetes model. The
results obtained with the mucous, muscular tunic, and
total wall suggest that variations in these parameters are
directly related to the period of maintenance of the dia-
betic state. Another factor suggested by Belai et al. [33] is
that diabetes mellitus differentially affects the intestines,
with the small intestine more susceptible than the large
intestine.
The thickness of the total intestinal wall, mucous, and
muscular tunic of the proximal colon in diabetic animals
was not affected by vitamin E supplementation, inde-
pendent of concentration. An absence of effect of vitamin
E was observed by Shirpoor et al. [37] for villi height and
crypt depth in the small intestine of diabetics animals.
Glutamine supplementation, a precursor of an important
antioxidant agent, glutathione, also did not alter crypt
depth or cell proliferation in the colonic mucosa of dia-
betic rats [32].
Quantitative analysis of goblet cells did not reveal signifi-
cant differences among groups in a study by Mantle et al.
[5], in which an increase in number of goblet cells in
intestinal villi was found in the small intestine of rats with
acute diabetes. An increase in the number of goblet cells
in crypts of the small intestine of diabetic mice was
reported by Ettarh and Carr [38], who suggested that the
increase in goblet cells directly related to an increase in
mucous tunic. These results suggest the conservation of
the mucous tunic in diabetic animals, which would justify
the maintenance of this cellular population as a morpho-
functional adaptation to the chronic diabetes condition.
Neuronal quantification revealed a significant reduction
in the number of myenteric neurons in animals from the
diabetic group compared with normoglycemic animals.
This is an expected result for rats [9,10,12-14], supported
by histochemical and immunohistochemical data from
different segments of the gastrointestinal tract [11,32,39].
The marked glycemia caused by the diabetic condition has
been considered to be the main factor involved in the
development and progression of neuropathy, promoting
abnormalities in blood flow and increasing vascular per-
meability, in addition to decreasing neuronal cell trophic
factors [16]. A reduction in antioxidant systems in diabe-
tes, including vitamins A, C, and E, glutathione, and glu-
tathione peroxidase, also contributes to the development
of neuropathy [40].
Administration of vitamin E (2%) had a neuroprotective
effect, conserving the number of myenteric neurons in
group DE2 compared with groups D and DE1. Cotter et al.
[23] found that the reduction in the velocity of nervous
system conductance could be attenuated in diabetics rats
with vitamin E at a concentration of 0.1%. According to
these authors, in experimental diabetes, glycemic levels
and the increase in free radicals are excessive compared
with patients whose diabetes is well controlled. This may
explain why a neuroprotective effect was not observed in
group DE1 (0.1%). The decreased neuronal loss in groupPage 6 of 8
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tiates the antioxidant system, in which erythrocytes in dia-
betic rats promote an increase in glutathione and
antioxidant enzymes, such as superoxide dismutase and
glutathione peroxidase [18]. Additionally, the develop-
ment of diabetic neuropathy is associated with mitochon-
drial dysfunction which consequently generates reactive
oxygen species, which are related to activation of a cascade
of events leading to apoptosis [41,42]. Therefore, vitamin
E supplementation may have minimized these events to
reduce neuronal death in group DE2.
When the average area of cellular bodies was assessed, sig-
nificant differences were not observed when diabetic
groups were compared with normoglycemic animals. The
increase in the area of neuronal cell bodies was observed
in diabetic rats [8,39], an effect attributed to an increase in
neuronal synthesis compensating for the neuronal death,
thus leading to an increase in cellular volume [39].
The results of the present study are similar to Tashima et
al. [32] with regard to the area of myosin-V neurons in the
proximal colon of diabetic rats. The myosin-V immuno-
histochemistry technique is a marker for total neuronal
population. However, Zanoni et al. [39] found an
increased area of these VIPergic neurons in diabetics rats,
possibly attributable to greater neuropeptide synthesis by
these cells. According to Tashima et al. [32], diabetes mel-
litus directly affects neuronal subpopulations in the gas-
trointestinal tract, suggesting that techniques which
identify total neuronal population, such as the myosin-V
immunohistochemistry and Giemsa techniques, do not
demonstrate these alterations.
Importantly, a statistically significant decrease in the area
of neuronal cellular bodies was observed in group DE2
compared with groups D and DE1, indicating a positive
influence of vitamin E (2%) on this parameter. These
results are corroborated by Zanoni et al. [39], in which
supplementation with ascorbic acid prevented the
increase in VIPergic neurons in the ileum of diabetic rats.
Our results indicate that vitamin E (2%) has a neuro-
trophic role by maintaining neuronal cellular bodies in
diabetic animals.
Conclusion
Supplementation with vitamin E (2%) in rats with
chronic diabetes mellitus positively influenced glycemia,
had neuroprotective effects on myenteric neurons, and
did not affect the morphological characteristics of the
intestinal wall.
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